dash riprock
- 9
- 3
Strong competitive position in a highly specialized and regulated field. We believe we are uniquely positioned to benefit from the significant potential within the field of cannabinoid therapeutics in which we have developed a successful track record and expertise during our 15 years of operations. In addition, we believe the highly specialized area of research and high degree of international regulations by governmental authorities, create substantial barriers to entry. We have an intellectual property portfolio including 46 patent families with issued and/or pending claims directed to plants, plant extracts, extraction technology, pharmaceutical formulations, drug delivery and the therapeutic uses of cannabinoids. Supplementing our traditional intellectual property, we own plant variety rights and possess a significant body of know-how and trade secrets pertaining to plant breeding and growing.
LOL... really?!?GW does not believe that an oral (swallowed) or inhaled formulation is optimal in administering a cannabinoid formulation containing THC.
No. GW supports the evidence-based approach to developing new medications according to the FDA approval process. Sativex is standardized in composition, thoroughly tested and quality-assured, and administered in a controlled and defined dose in an appropriate manner. Sativex contains both THC and CBD, and both preclinical and clinical studies suggest that CBD may lessen many of the negative effects of THC, including intoxication. The Sativex clinical development program is designed to demonstrate that it is possible to develop a cannabis-derived medication in accordance with modern medical standards--such as those established by the FDA process--as is the case with all other medications prescribed for serious medical conditions. Products that have gone through the FDA process have demonstrated that they are safe and efficacious for a particular medical condition; that they have been manufactured in accordance with properly validated quality-control processes; that they are highly standardized and consistent batch-to-batch; and that they provide a fixed and reproducible dose; and that they may be reimbursed by the patient’s health care insurance program.
The business [HORTIPHARM]was founded by David Paul Watson in 1990. He was soon joined by David W. Pate and eventually Robert C. Clarke. They obtained the first license issued by the Dutch government to permit a Cannabis research facility in the Netherlands. HortaPharm B.V. has a partnership with GW Pharmaceuticals to develop Cannabis varieties for the manufacture of pharmaceuticals.
When Geoffrey came over here in 1998, we were getting close to our financial limit. We're an R&D company — we didn't have a product that was making an income. The problem for Geoffrey is that all cannabis experts have backgrounds — they've built their expertise by working with an illegal material. But Hortapharm was fully licensed by the Dutch government. So Geoffrey got a legal supply of pharmaceutical grade germ-plasm. And he got me and Robert Clarke to pass along our knowledge. We gave him at least a five-year head start.
Drs. Geoffrey Guy and Brian Whittle founded GW Pharmaceuticals in 1998. In the same year, they obtained the only cultivation license in the United Kingdom from the Home Office and the MHRA, allowing GW Pharmaceuticals to cultivate cannabis from seeds and clones to conduct scientific research concerning the medicinal uses of the plant.
In July 1998, GW Pharmaceuticals collaborated with HortaPharm B.V., a cannabis research and development business based in the Netherlands,[8] founded by two expert horticulturists from California,[9] Robert Connell Clarke[10] and David Paul Watson, also known as 'Sam the Skunkman'. [11] HortaPharm grew medicinal strains for the Dutch government.
GW is developing specialist security technology which can be applied to all of its drug delivery systems.
The aim of this anti-diversionary technology is to prevent any potential abuse of cannabis-based
medicines. In addition, this technology is being designed to enable the recording and remote monitoring of
patient usage. The technology should recognise and prevent any abnormal use that differs from expected
prescribed usage. Such data would itself have intrinsic value and would also allow for efficient monitoring
in clinical trials. The first set of prototypes for the technology as applied to the sub-lingual spray pump has
been developed and two patent applications have been filed.
This technology has potential applications for the delivery of other drugs, in particular controlled drugs
such as opiates and benzodiazapenes. GW will in due course be evaluating options for the licensing of this
technology to other pharmaceutical companies.
Following introductions from the Home Office on behalf of GW, GW has held meetings with the Food and
Drug Administration (FDA), the Drug Enforcement Agency (DEA) and the Office for National Drug Control
Policy (ONDCP). In addition, GW has met with NIDA and senior State officials in California and Maine.
Although the licensing process in the US is often protracted, GW has recently received its first US import
licence from the DEA. In August 2000, ONDCP commented publicly on medicinal cannabis as follows: “To
have medicine determined by science and not by popular will is exactly what we support.’
Hortapharm BV licence
GW has entered into an exclusive worldwide collaboration with the Dutch medicinal cannabis breeding
specialists Hortapharm BV. Further details of the agreement with Hortapharm are set out in paragraph 11
of Part VIII. Hortapharm has been researching the cannabis plant for a decade. Its staff include individuals
who have published several works on cannabis botany. Hortapharm has also developed techniques for
breeding varieties of cannabis of a pre-determined cannabinoid composition. By obtaining access to all of
Hortapharm’s relevant know-how and relevant plant varieties (present and future), the Directors believe
that GW’s cultivation programme has been accelerated by several years.
Intellectual property rights
An integral part of the research and development programme is to establish proprietary intellectual
property rights to protect techniques and technologies involved in the development programme.
Examples of the areas in which the Group is and will be seeking protection in the future are as follows:
plant variety rights
methods of extraction patents
drug delivery device patents
patents on compositions of matter for the delivery of cannabis
methods of use patents
design copyright on devices
trade marks
The Group’s aim is to develop a matrix of interlocking intellectual property rights which is difficult for
competitors to penetrate. The Group has considerable know-how which is backed by a growing number of
patent applications and it is in this intellectual property where much of the value of the Group lies. The
maintenance, strengthening and expansion of its portfolio of intellectual property is a priority for the
Group.
The objective of my principals is to ‘grow cannabis, manufacture Sativex and sell it within China’
The story of Sativex begins, perhaps unsurprisingly, in Amsterdam. An expat Californian named David Paul Watson, after years of wandering the globe compiling a library of cannabis types, had settled there. In 1997, the company he cofounded, HortaPharm, received the Dutch Ministry of Health, Welfare and Sport’s first license to cultivate cannabis for medical research.
HortaPharm developed the first homozygote cannabis (a plant with two identical sets of chromosomes), enabling the company to produce strains overwhelmingly high in a single cannabinoid. It’s long been known that THC is the “active ingredient” in pot—it’s what gets a person stoned. But more recent research has found numerous other cannabinoids in the plant, which have different effects on the body. One that’s shown early promise for antiseizure and antianxiety properties is cannabidiol, or CBD. Watson could grow plants that were 98 percent THC, or 98 percent CBD, or whatever. (The hash oil treatments given to the girl on CNN are from high-CBD strains, and GW’s antiseizure medication is high-CBD.)
HortaPharm soon crossed paths with Dr. Geoffrey Guy, who in 1998 received a license from the British government to grow pot for medical R&D for his company: GW Pharmaceuticals. Guy was searching for a legal source of plant materials with varying compositions of cannabinoids. He wanted to hybridize different plant strains so he could test the effects of various combinations of cannabinoids on various maladies.
GW creates Sativex by processing cannabis plants it grows in secret facilities at an undisclosed location in the UK. Sativex cost £100m to develop and was based on selective breeding of two different types of cannabis plant that were acquired in 1998 from Dutch cannabis researchers Horta Pharm, which has a non-disclosed share in the success of Sativex.
Can I copy and paste parts of this with my account on icmag so that it gets deleted too?I was recently banned from ICmag (familiar story I know) but the reason I was banned was because I was arguing with skunkman about ownership of genetics. Apparently he is currently soliciting the growers on ICmag forums to send him any and all seed (even the dead ones) that they have so he can send it to a lab in Oregon named Phylos Biosciences to have the DNA sequenced.
http://phylosbioscience.com/about/
I was banned and all my posts deleted when I told others that in light of skunkmans past abuses with genetics ie selling his library to GW Pharmaceuticals who then sold the patent for Sativex (made from skunkman and RCC genes out of hortapharm for a rumored 7 figures). I'm actually unsure about the financial details, but hortapharm definitely sold their strains to GW who then hooked up with Bayer (a subsidiary of the Nazi war machines I.G Farben) so I am kind of pissed. I figured the best place to have this conversation was with skunkman himself but he is (a megalomaniac?) pretty unreasonable, and I say that because instead of talking about this he just brought down the banhammer on me.
The point being are we as a community (a worldwide community of cannabis lovers) going to allow two men with one company attempt to lay claim to any drug cultivar they find and then have it sequenced and lay claim to ownership? This is a truly frightening turn of events, what if in the future you are caught growing a strain that these companies have trademarked or claimed as intellectual property? Let's remember Bayer has a monster legal team, billions of dollars at their disposal, and a known track record of highly unethical (criminal) behavior. I am still stunned that people I looked up to are selling all of us down the river to big pharma, so they can sleep on silk sheets and leave a "legacy" or some stupid shit. The owners of hortapharm no longer care about the plant or the community they have decided to sleep with the enemy to further their own selfish desires.
I hope this is the right place for this thread, but this is like an elephant in the room. I cannot confirm the intentions of hortapharm or ICmag, but from past history, it will be at the expense of smaller local growers.
Yes, that works but I am going to repost the link anyway just for ease of access.Israel is patenting strains now:
Ok, well replace invalid.com with invalid.com and the link should work....
Geezus effin criminey.... marijuana dot com....will this work?
Almost hard to believe it but I got banned from IC before by ole Sammy too lol, dude is a f'n egotistical joke. Now no matter what I've posted in a thread over there if he joins the convo it seems like it's only to disagree with or troll my post. I think anyone that doesn't agree with his "all knowing godlike canna knowledge" walks on thin ice over there...... a speak in Layman's terms so peeps can follow me, he tries to drop all these big words that half the folks are truly lost once he opens his mouth, I know about some of these big word users lol. He got so bad at one point I had to tell him to stop living off the past and go breed something new for crying out loud. I now avoid posting in the same threads as him and if he post after me I don't reply.
The fact that I have never smoked a sample of Skunk #1 that was worthy of growing out or had any type of roadkill smell to it suggest that all he did was attach the Skunk name to it just to increase seed sales in the US...... a model that has been adopted by every bunk seed breeder since, His only canna legacy in my eyes is that he f'd up the RKS. And I'll bet the barn he started that bs statement about Sk1 being in the majority of indoor strains/crosses available....... lmao it felt good getting that off my chest it's been 2 years overdue! I've chucked better stuff with just 10 beans than he has with his "10,000 plant selection method," fool probably culled all the best plants lol, well you're part of the Farm now, you can disagree with someone as long as you're being respectful of others you shouldn't get the hammer round here!
Interesting read here on the subject , can't seem to link the thread and lost it ....google ...lifetime ic member gets banned ....@mns seedsAlmost hard to believe it but I got banned from IC before by ole Sammy too lol, dude is a f'n egotistical joke. Now no matter what I've posted in a thread over there if he joins the convo it seems like it's only to disagree with or troll my post. I think anyone that doesn't agree with his "all knowing godlike canna knowledge" walks on thin ice over there...... a speak in Layman's terms so peeps can follow me, he tries to drop all these big words that half the folks are truly lost once he opens his mouth, I know about some of these big word users lol. He got so bad at one point I had to tell him to stop living off the past and go breed something new for crying out loud. I now avoid posting in the same threads as him and if he post after me I don't reply.
The fact that I have never smoked a sample of Skunk #1 that was worthy of growing out or had any type of roadkill smell to it suggest that all he did was attach the Skunk name to it just to increase seed sales in the US...... a model that has been adopted by every bunk seed breeder since, His only canna legacy in my eyes is that he f'd up the RKS. And I'll bet the barn he started that bs statement about Sk1 being in the majority of indoor strains/crosses available....... lmao it felt good getting that off my chest it's been 2 years overdue! I've chucked better stuff with just 10 beans than he has with his "10,000 plant selection method," fool probably culled all the best plants lol, well you're part of the Farm now, you can disagree with someone as long as you're being respectful of others you shouldn't get the hammer round here!
Can I copy and paste parts of this with my account on icmag so that it gets deleted too?
And topic related.
Big money is moving in and they want all the chemical rights to this wonder plant. Dont be suprised when we see our favorite breeders sell out to big pharma.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?